Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups Precipio, Inc.January 20, 2021 GMT NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US, West Cancer Center of Memphis, TN; and New York Cancer & Blood Specialists of New York. During the coming weeks, both practices will be bringing Precipio’s HemeScreen technology in-house. The impleme...